Travatan Z Approval History
- FDA approved: Yes (First approved September 21st, 2006)
- Brand name: Travatan Z
- Generic name: travoprost
- Dosage form: Ophthalmic Solution
- Company: Alcon, Inc.
- Treatment for: Glaucoma
Travatan Z (travoprost) is a new formulation of Travatan solution in which benzalkonium chloride is replaced with Sofzia, a robust ionic buffered preservative system that is gentle to the ocular surface. Travatan Z is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, who are intolerant of or insufficiently responsive to other intraocular pressure lowering medications.
Development History and FDA Approval Process for Travatan Z
|Sep 21, 2006||Travatan Z Alcon, Inc. - Treatment for Glaucoma and Ocular Hypertension|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.